402 related articles for article (PubMed ID: 33126856)
1. Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison.
Okafor IM; Ugwu SO; Okoroiwu HU
BMC Gastroenterol; 2020 Oct; 20(1):360. PubMed ID: 33126856
[TBL] [Abstract][Full Text] [Related]
2. Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.
Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Boamah I; Adu-Gyamfi C; Asare I; Hesse IF; Mensah G
BMC Infect Dis; 2008 Mar; 8():33. PubMed ID: 18328097
[TBL] [Abstract][Full Text] [Related]
3. Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria.
Adoga MP; Banwat EB; Forbi JC; Nimzing L; Pam CR; Gyar SD; Agabi YA; Agwale SM
J Infect Dev Ctries; 2009 Aug; 3(7):539-47. PubMed ID: 19762972
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.
Belaunzarán-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Sierra-Madero JG; Ahmed S; Beyrer C
PLoS One; 2017; 12(6):e0179931. PubMed ID: 28654650
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of sexually transmitted and blood-borne infections amongst the inmates of a district jail in Northern India.
Singh S; Prasad R; Mohanty A
Int J STD AIDS; 1999 Jul; 10(7):475-8. PubMed ID: 10454185
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Hepatitis C Virus among Prisoners in Lakan Prison, North of Iran, Is There Still a Concern?
Mohtasham-Amiri Z; Rezvani SM; Ashoori F; Behboodi M; Toosi H; Jafari-Shakib R
Arch Iran Med; 2021 Oct; 24(10):765-770. PubMed ID: 34816699
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana.
Adjei AA; Armah HB; Gbagbo F; Ampofo WK; Quaye IKE; Hesse IFA; Mensah G
J Med Microbiol; 2006 May; 55(Pt 5):593-597. PubMed ID: 16585647
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.
Tadesse K; Ayalew G; Million Y; Gelaw A
PLoS One; 2024; 19(4):e0301973. PubMed ID: 38626232
[TBL] [Abstract][Full Text] [Related]
9. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
10. Tattooing in prison: a risk factor for HCV infection among inmates in the Quebec's provincial correctional system.
Poulin C; Courtemanche Y; Serhir B; Alary M
Ann Epidemiol; 2018 Apr; 28(4):231-235. PubMed ID: 29576049
[TBL] [Abstract][Full Text] [Related]
11. The seroprevalence of untreated chronic hepatitis C virus (HCV) infection and associated risk factors in male Irish prisoners: a cross-sectional study, 2017.
Crowley D; Lambert JS; Betts-Symonds G; Cullen W; Keevans M; Kelly E; Laird E; McHugh T; McKiernan S; Miggin SJ; Murphy C; Murtagh R; O'Reilly D; Tobin C; Van Hout MC
Euro Surveill; 2019 Apr; 24(14):. PubMed ID: 30968825
[TBL] [Abstract][Full Text] [Related]
12. [Seroprevalence of hepatitis C virus infection at the time of entry to prison in the prison population in the north-east of Spain].
Martín Sánchez V; Ferrer Castro V; Pallas Álvarez JR; Alonso Herrero LE; Andrés Honorato M; Coterillo González MJ; García Marcos LS; González Márquez J; Hernández Alonso I; LLanos Gallegos M; Mallada García E; Martínez Martínez ML; Morillo Pérez M; Pérez Martínez I; Valles Martínez J
Rev Esp Salud Publica; 1998; 72(1):43-51. PubMed ID: 9477715
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of and risk factors for HCV among incarcerated people at Great Tehran Prison: a cross-sectional study.
SeyedAlinaghi S; Farhoudi B; Shahmohamadi E; Rasoolinejad M; Hasannezhad M; Rashidi MR; Dadras O; Moradi A; Parmoon Z; Ebrahimi H; Asadollahi-Amin A
Int J Prison Health; 2023 Feb; ():. PubMed ID: 36757302
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of hepatitis C infection in a Brazilian prison: identification of risk factors for infection.
Guimarães T; Granato CF; Varella D; Ferraz ML; Castelo A; Kallás EG
Braz J Infect Dis; 2001 Jun; 5(3):111-8. PubMed ID: 11506773
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis B and hepatitis C infections and their relationship to injectable drug use in a cohort of Sri Lankan prison inmates.
Niriella MA; Hapangama A; Luke HP; Pathmeswaran A; Kuruppuarachchi KA; de Silva HJ
Ceylon Med J; 2015 Mar; 60(1):18-20. PubMed ID: 25804913
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy.
Semaille C; Le Strat Y; Chiron E; Chemlal K; Valantin MA; Serre P; Caté L; Barbier C; Jauffret-Roustide M;
Euro Surveill; 2013 Jul; 18(28):. PubMed ID: 23870097
[TBL] [Abstract][Full Text] [Related]
18. Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico.
Belaunzaran-Zamudio PF; Mosqueda-Gomez JL; Macias-Hernandez A; Rodríguez-Ramírez S; Sierra-Madero J; Beyrer C
AIDS Res Hum Retroviruses; 2017 Jun; 33(6):524-533. PubMed ID: 28094553
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
[TBL] [Abstract][Full Text] [Related]
20. HCV seropositivity in inmates and in the general population: an averaging approach to establish priority prevention interventions.
Roux P; Sagaon-Teyssier L; Lions C; Fugon L; Verger P; Carrieri MP
BMJ Open; 2014 Oct; 4(10):e005694. PubMed ID: 25331969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]